TaiMed Biologics Net Asset Quality Index
TaiMed Biologics net asset quality index. TaiMed Biologics (4147) has a Net Asset Quality Index of 81.7% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of NT$4.50 Billion minus total liabilities of NT$824.49 Million yields net assets of NT$3.68 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check 4147 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of TaiMed Biologics (2009–2025)
Net asset quality index of TaiMed Biologics from 2009 to 2025. This chart shows how TaiMed Biologics's Net Asset Quality Index has evolved across 17 annual periods from 2009 to 2025. As of June 2026, the index stands at 81.7%, representing net assets of NT$3.68 Billion against total assets of NT$4.50 Billion TWD. See 4147 total equity for net asset value and shareholders' equity analysis.
TaiMed Biologics Net Asset Quality Index by Year (2009–2025)
TaiMed Biologics net asset quality index by year from 2009 to 2025. The table below presents the year-by-year Net Asset Quality Index for TaiMed Biologics from 2009 to 2025, covering 17 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see TaiMed Biologics stock valuation.
| Year | Quality Index | Net Assets (TWD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 80.2% | NT$3.86 Billion | NT$4.81 Billion | NT$953.05 Million | ▼ -0.3 pp |
| 2024 | 80.5% | NT$4.02 Billion | NT$5.00 Billion | NT$976.34 Million | ▲ +14.6 pp |
| 2023 | 65.9% | NT$2.57 Billion | NT$3.89 Billion | NT$1.33 Billion | ▼ -0.3 pp |
| 2022 | 66.2% | NT$2.71 Billion | NT$4.10 Billion | NT$1.39 Billion | ▲ +2.4 pp |
| 2021 | 63.8% | NT$2.94 Billion | NT$4.61 Billion | NT$1.67 Billion | ▼ -1.9 pp |
| 2020 | 65.7% | NT$3.42 Billion | NT$5.20 Billion | NT$1.78 Billion | ▼ -10.1 pp |
| 2019 | 75.8% | NT$3.59 Billion | NT$4.73 Billion | NT$1.14 Billion | ▼ -9.4 pp |
| 2018 | 85.2% | NT$4.08 Billion | NT$4.79 Billion | NT$710.55 Million | ▼ -10.2 pp |
| 2017 | 95.3% | NT$4.29 Billion | NT$4.50 Billion | NT$210.71 Million | ▼ -2.8 pp |
| 2016 | 98.2% | NT$4.71 Billion | NT$4.80 Billion | NT$87.99 Million | ▼ -1.3 pp |
| 2015 | 99.5% | NT$4.90 Billion | NT$4.93 Billion | NT$26.63 Million | ▲ +2.1 pp |
| 2014 | 97.3% | NT$1.83 Billion | NT$1.88 Billion | NT$50.35 Million | ▲ +5.3 pp |
| 2013 | 92.0% | NT$657.73 Million | NT$714.72 Million | NT$56.99 Million | ▼ -5.8 pp |
| 2012 | 97.8% | NT$645.21 Million | NT$659.45 Million | NT$14.23 Million | ▼ -0.4 pp |
| 2011 | 98.2% | NT$839.24 Million | NT$854.39 Million | NT$15.15 Million | ▼ -0.2 pp |
| 2010 | 98.4% | NT$1.04 Billion | NT$1.06 Billion | NT$16.88 Million | ▲ +1.5 pp |
| 2009 | 96.9% | NT$598.14 Million | NT$617.22 Million | NT$19.08 Million | — |